Filing Details

Accession Number:
0001179110-20-009704
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-11 20:34:42
Reporting Period:
2020-09-09
Accepted Time:
2020-09-11 20:34:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc., 201 Industrial Road
Suite 410
San Carlos CA 94070
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-09 3,021 $0.00 57,466 No 4 M Direct
Common Stock Disposition 2020-09-10 1,236 $60.77 56,230 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2020-09-09 3,021 $0.00 3,021 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,125 No 4 M Direct
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 9, 2019.
  2. Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  3. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs. The Reporting Person is subject to a Lock-Up Letter Agreement. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.76 to $61.15 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. These reported shares are subject to restrictions in a Lock-Up Letter Agreement that expire on November 10, 2020.
  6. The RSUs vest over four years. 25% of the RSUs vest on March 9, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.